CCIA
HAE icon

Campbell & Co Investment Adviser’s Haemonetics HAE Stock Holding History

Campbell & Co Investment Adviser’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76M Buy
36,844
+25,495
+225% +$1.64M 0.14% 222
2026
Q1 		$640K Sell
11,349
-75,547
-87% -$4.92M 0.04% 665
2025
Q4 		$6.96M Buy
86,896
+80,039
+1,167% +$5.38M 0.33% 47
2025
Q3 		$334K Buy
+6,857
New +$424K 0.03% 875
2025
Q2 		– Sell
-6,615
Closed -$420K – 1258
2025
Q1 		$420K Sell
6,615
-8,851
-57% -$602K 0.03% 754
2024
Q4 		$1.21M Sell
15,466
-1,438
-9% -$116K 0.09% 326
2024
Q3 		$1.36M Buy
+16,904
New +$1.37M 0.1% 316
2024
Q2 		– Sell
-15,506
Closed -$1.32M – 1155
2024
Q1 		$1.32M Sell
15,506
-8,341
-35% -$655K 0.11% 281
2023
Q4 		$2.04M Buy
+23,847
New +$2.06M 0.18% 126
2023
Q3 		– Sell
-6,264
Closed -$533K – 1043
2023
Q2 		$533K Sell
6,264
-11,306
-64% -$956K 0.1% 400
2023
Q1 		$1.45M Buy
17,570
+3,223
+22% +$261K 0.27% 69
2022
Q4 		$1.13M Buy
+14,347
New +$1.15M 0.27% 77
2022
Q3 		– Sell
-3,247
Closed -$212K – 790
2022
Q2 		$212K Buy
+3,247
New +$192K 0.06% 588
2020
Q1 		– Sell
-2,403
Closed -$276K – 230
2019
Q4 		$276K Sell
2,403
-265
-10% -$32.1K 0.08% 457
2019
Q3 		$337K Buy
+2,668
New +$339K 0.13% 333

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Campbell & Co Investment Adviser's HAE Position: Q2 2026 in Review

Campbell & Co Investment Adviser increased its Haemonetics (HAE) stake by 225% in Q2 2026, buying an estimated $1.64M and bringing the position to 36,844 shares worth $2.76M. The position accounts for 0.14% of the portfolio, ranked #222.

Campbell & Co Investment Adviser first reported a position in HAE in Q3 2019 and has held it in 15 quarters since. The position peaked at $6.96M in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Campbell & Co Investment Adviser held 36,844 shares of Haemonetics worth $2.76M as of Q2 2026.
  • Campbell & Co Investment Adviser bought 25,495 Haemonetics shares in Q2 2026, an estimated $1.64M.
  • Haemonetics made up 0.14% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #222 holding.
  • Campbell & Co Investment Adviser first reported a position in Haemonetics in Q3 2019 and has held it in 15 quarters since.
  • Campbell & Co Investment Adviser's Haemonetics position peaked at $6.96M in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.